Skip to Main Content
Skip Nav Destination

Issue Archive

Table of Contents

Ham-Wasserman Lecture

Acute Myeloid Leukemia: Improving Outcomes in Challenging Subsets

Anxiety Provoking Consultations: Mast Cells and Eosinophils

Are Alternative Donors Now Mainstream in Allogeneic Transplant?

Autoimmune Hemolytic Anemias

Beyond Routine Frontline Therapy of CML

Controversies in Aggressive NHL

Immunotherapy in Multiple Myeloma

Improving Outcomes in ALL

JAK/STAT Inhibition and Beyond in Ph-Negative MPNs

Long-Term Effects Monitoring for Survivors of Pediatric Hematologic Malignancies

Long-Term Health Effects of Curative Therapy for Sickle Cell Disease

Managing Thrombocytopenia in Challenging Situations

Maximizing Outcomes in CLL

Multiple Myeloma: Assessing the Patient and the Disease

Novel Approaches in MDS

Obstetric Management and Complications in Sickle Cell Disease in High- and Low-Income Countries

Prophylactic Platelet Transfusions

Reproductive and Sexual Health in Sickle Cell Disease

Thrombosis and Anticoagulation: Clinical Considerations in Selected Populations

Thrombosis Prevention and Treatment

To Transplant or Not to Transplant in Active or High-Risk Myeloid Disease

Treatment Approaches for the Multiple Myeloma Patient in 2022

Update in Hemophilia

Updates in Targeted Therapy in Pediatric Leukemia

Von Willebrand Disease

What is New in Classical Bone Marrow Failure Syndromes? (Focus on Management)

What's New in Indolent Lymphoma

Where Are We Headed in Hodgkin Lymphoma?


Close Modal

or Create an Account

Close Modal
Close Modal